These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16967708)

  • 1. Economics of type 2 diabetes prevention.
    Kissimova-Skarbek K
    Przegl Lek; 2006; 63 Suppl 4():9-11. PubMed ID: 16967708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaco-economics of type 2 diabetes].
    Scheen AJ; Lefèbvre PJ
    Rev Med Liege; 1998 May; 53(5):285-9. PubMed ID: 9689884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of type 2 diabetes mellitus: proven and new aspects].
    Ritzel RA; Isermann B; Woerle HJ
    Dtsch Med Wochenschr; 2007 May; 132(19):1057-61. PubMed ID: 17476638
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention and early therapy play too minor a role in our health care system].
    Rothe HJ
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():22-3. PubMed ID: 14694840
    [No Abstract]   [Full Text] [Related]  

  • 5. Should future health-care costs be discounted? The case of diabetes in Australia.
    Scuffham PA
    Intern Med J; 2006 Mar; 36(3):148-9. PubMed ID: 16503948
    [No Abstract]   [Full Text] [Related]  

  • 6. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery.
    Makary MA; Clark JM; Shore AD; Magnuson TH; Richards T; Bass EB; Dominici F; Weiner JP; Wu AW; Segal JB
    Arch Surg; 2010 Aug; 145(8):726-31. PubMed ID: 20713923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost.
    Athanasakis K; Ollandezos M; Angeli A; Gregoriou A; Geitona M; Kyriopoulos J
    Diabet Med; 2010 Jun; 27(6):679-84. PubMed ID: 20546287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs of non-insulin-dependent diabetes mellitus.
    Alberti KG
    Diabet Med; 1997 Jan; 14(1):7-9. PubMed ID: 9017347
    [No Abstract]   [Full Text] [Related]  

  • 9. ["The Lantus Case": What is the benefit of health economics?].
    Schöffski O
    Dtsch Med Wochenschr; 2010 May; 135(20):1033-5. PubMed ID: 20461663
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics.
    Levin P
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():66-75. PubMed ID: 18577158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic evaluation of drugs. Effectiveness in diabetes therapy].
    Schöffski O
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S106-9; discussion S124-6. PubMed ID: 18686218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment.
    Walson PD; Mullins CD; Lyles A; West JA
    Clin Ther; 2008 Oct; 30(10):1889. PubMed ID: 19014844
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New, expensive antidiabetics for the treatment of type-2 diabetes--pro].
    Müller-Wieland D
    Dtsch Med Wochenschr; 2010 May; 135(18):922. PubMed ID: 20425678
    [No Abstract]   [Full Text] [Related]  

  • 15. [The German diabetes dilemma: DMP: insufficient management of the diabetic patient in general practice?].
    MMW Fortschr Med; 2005 Oct; 147(41):10. PubMed ID: 16270503
    [No Abstract]   [Full Text] [Related]  

  • 16. [An economic review of the management of diabetes mellitus].
    Tsujii S
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():623-30. PubMed ID: 12430293
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative approaches to reduce diabetes costs.
    Reese AB
    N C Med J; 2011; 72(5):409-12. PubMed ID: 22416528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obesity and diabetes mellitus: increasing problems call for increasing efforts].
    Nauck M
    Dtsch Med Wochenschr; 2010 May; 135(18):901. PubMed ID: 20425673
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of diabetes: a strategic approach for individual patients.
    Shin JA; Lee JH; Kim HS; Choi YH; Cho JH; Yoon KH
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():79-84. PubMed ID: 23280871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.